Canada - Re-Imbursed Pharmaceutical Market
Since 2014, Canada Re-Imbursed Pharmaceutical Market was down by 4.1points year on year. At 26.8 Percent of Generics in Value in 2019, the country was ranked number 6 among other countries in Re-Imbursed Pharmaceutical Market. Canada is overtaken by Germany, which was ranked number 5 with 32.9 Percent of Generics in Value and is followed by Greece with 25.3 Percent of Generics in Value. Austria ranked the highest with 52.2 Percent of Generics in Value in 2019, that is +2.8points compared to 2018. United Kingdom, Turkey and New Zealand respectively ranked number 2, 3 and 4 in this ranking. Denmark witnessed the best average annual growth at +6.9points per year, while Slovakia was the worst growing country at -7.8points per year.
Loading...
| Date | Percent of Generics in Value |
|---|---|
| 2019 | 26.80 |
| 2018 | 27.60 |
| 2017 | 29.30 |
| 2016 | 30.80 |
| 2015 | 31.40 |
How does Canada rank in Re-Imbursed Pharmaceutical Market?
| # | 17 Countries | Percent of Generics in Value | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Austria
|
52.20 % | 2019 | +2.8 % | +2.2 % | View data | |
| 2 |
#2
United Kingdom
|
38.50 % | 2019 | +2.1 % | +2.6 % | View data | |
| 5 |
#5
Germany
|
32.90 % | 2019 | +1.5 % | -1.9 % | View data | |
| 6 |
#6
Canada
|
26.80 % | 2019 | -2.9 % | -4.1 % | View data | |
| 7 |
#7
Greece
|
25.30 % | 2019 | +11.9 % | +5.9 % | View data | |